肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2014 中国成人肾病综合征免疫抑制治疗专家共识

2014-06-30 肾脏病相关专家小组（统称） 中华肾脏病杂志. 2014,30(6):467-474.

肾病综合征

中文标题：

2014 中国成人肾病综合征免疫抑制治疗专家共识

发布机构：

肾脏病相关专家小组（统称）

发布日期：

2014-06-30

简要介绍：

2012年KDIGO肾小球肾炎临床实践指南(以下简称KDIGO指南)发表后，对肾小球疾病的治疗起到了重要指导作用。但KDIGO指南所采用的资料截止到2011年11月，且纳入来自中国的临床研究证据较少。因此，有必要借鉴国际指南，结合中国肾科医生临床研究成果和治疗经验，制定符合中国实际情况的成人常见原发和继发肾病综合征的免疫抑制治疗专家共识，供中国肾科医生临床实践参考，并为将来进一步改进临床指南提供基础。附：图1 MCD治疗策略流程图图2 FSGS治疗策略流程图

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1226819, encodeId=1f2312268193b, content=看不了哎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22598167301, createdName=ms3000002010443378, createdTime=Thu Jun 16 15:08:50 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367417, encodeId=4bce36e4173d, content=没有原文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d072250589, createdName=12163b23m82暂无昵称, createdTime=Fri Jun 07 15:07:32 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292643, encodeId=d5bd292643ba, content=同问.怎么看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6b62189397, createdName=1208e5a2m68暂无昵称, createdTime=Sat Mar 03 16:50:53 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279839, encodeId=7b662e9839cc, content=怎么能看见原文呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Thu Jan 18 23:04:08 CST 2018, time=2018-01-18, status=1, ipAttribution=)]
    2022-06-16 ms3000002010443378

    看不了哎

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1226819, encodeId=1f2312268193b, content=看不了哎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22598167301, createdName=ms3000002010443378, createdTime=Thu Jun 16 15:08:50 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367417, encodeId=4bce36e4173d, content=没有原文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d072250589, createdName=12163b23m82暂无昵称, createdTime=Fri Jun 07 15:07:32 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292643, encodeId=d5bd292643ba, content=同问.怎么看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6b62189397, createdName=1208e5a2m68暂无昵称, createdTime=Sat Mar 03 16:50:53 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279839, encodeId=7b662e9839cc, content=怎么能看见原文呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Thu Jan 18 23:04:08 CST 2018, time=2018-01-18, status=1, ipAttribution=)]
    2019-06-07 12163b23m82暂无昵称

    没有原文？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1226819, encodeId=1f2312268193b, content=看不了哎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22598167301, createdName=ms3000002010443378, createdTime=Thu Jun 16 15:08:50 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367417, encodeId=4bce36e4173d, content=没有原文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d072250589, createdName=12163b23m82暂无昵称, createdTime=Fri Jun 07 15:07:32 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292643, encodeId=d5bd292643ba, content=同问.怎么看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6b62189397, createdName=1208e5a2m68暂无昵称, createdTime=Sat Mar 03 16:50:53 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279839, encodeId=7b662e9839cc, content=怎么能看见原文呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Thu Jan 18 23:04:08 CST 2018, time=2018-01-18, status=1, ipAttribution=)]
    2018-03-03 1208e5a2m68暂无昵称

    同问.怎么看原文

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1226819, encodeId=1f2312268193b, content=看不了哎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22598167301, createdName=ms3000002010443378, createdTime=Thu Jun 16 15:08:50 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367417, encodeId=4bce36e4173d, content=没有原文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d072250589, createdName=12163b23m82暂无昵称, createdTime=Fri Jun 07 15:07:32 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292643, encodeId=d5bd292643ba, content=同问.怎么看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a6b62189397, createdName=1208e5a2m68暂无昵称, createdTime=Sat Mar 03 16:50:53 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279839, encodeId=7b662e9839cc, content=怎么能看见原文呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Thu Jan 18 23:04:08 CST 2018, time=2018-01-18, status=1, ipAttribution=)]
    2018-01-18 1e160a78m83(暂无匿称)

    怎么能看见原文呢

    0

相关指南

2010年成人原发性肾病综合征治疗专家共识

肾脏病相关专家小组（统称） · 2010-03-30

2010 中国儿童常见肾脏疾病诊治循证指南(试行)(三)： 激素耐药型肾病综合征诊治指南

中华医学会儿科学分会肾脏病学组 · 2010-01-01